IGF1 and atherosclerosis: The negative changes of IGF-1 in T2DM can lead to CVD problems through two perspectives, namely atherosclerosis, inflammation, vasodilation, cardiac apoptosis, and autophagy, and by affecting the PI3K/Akt cascade11,12.